Biotech stocks operate under a core ethos. While there’s been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals… Read More »7 Breakthrough Biotech Stocks For A Shot Of Portfolio Adrenaline
Just when you thought it was safe to go outside, monkeypox pops up. This might not be bad news for the market, as the world… Read More »Moneypox Outbreak Puts Focus On These Two Biotechs
While there may be little difference between the COVID-19 vaccines developed by BioNTech and Moderna, there are some significant differences between the two companies –… Read More »Do Investors Have A Better Shot With BioNTech Or Moderna?
Of the hundreds of biotech stocks on the market, if there’s one that investors should really have on their radars right now, this may be… Read More »1 Biotech Stock To Single Out
Of the eight globally listed exchange traded products that track the Nasdaq Biotechnology Index (the gold standard of biotech indexes), this newly minted ETF is… Read More »This Biotech ETF Is New, Practical & Cost-Effective
Big news for one stock can result in sympathy moves for other stocks. So, in the wake of big news for Biogen with the FDA… Read More »Sympathy Moves On Biogen’s Big News
Biotech stocks have been retreating, as have small-cap stocks. But this ETF at the intersection of both could still be a great bet. CLICK HERE.
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
Radiation, surgery, chemotherapy…and electric fields? This oncology company has developed a fourth paradigm for treating cancer – and has multiple data readouts this year that… Read More »A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
As has been on full display in recent weeks, developing an effective vaccine is one thing. Rolling it out efficiently is another. As one tech/industrial… Read More »A Way To Play This Vaccine Rollout Partnership